MRK vs OSRH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MRK shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.
OSRH exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic Current Ratio of 0.16, indicating an inability to meet short-term obligations. The company is experiencing a collapse in top-line growth with revenue declining 58.30% YoY, coupled with an unsustainable operating margin of -1674.81%. While the Price-to-Book ratio of 0.19 suggests deep value, the lack of liquidity and negative earnings trajectory point toward a high risk of insolvency. The single analyst target of $10.00 is completely decoupled from the current fundamental reality.
Compare Another Pair
Related Comparisons
MRK vs OSRH: Head-to-Head Comparison
This page compares Merck & Co., Inc. (MRK) and OSR Holdings, Inc. (OSRH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.